BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2019
View Archived Issues
New insights into old Fountain of Youth
Read More
Preclearance boosts immunotherapy in pancreatic cancer
Read More
New vaccine protects nonhuman primates against equine encephalitis viruses
Read More
Preclinical evaluation of enzymatically cleavable lipoglycopeptides for pulmonary MRSA
Read More
FDA clears Syndax's IND for phase I/II trial of SNDX-5613 for relapsed/refractory acute leukemias
Read More
First patient dosed in phase II study of KD-025 in cutaneous systemic sclerosis
Read More
Researchers develop CRISPR/Cas9 hemophilia A murine model
Read More
Guangdong Newopp Biopharmaceuticals presents new arginase inhibitors
Read More
Chiesi discovers Rho kinase inhibitors
Read More
New PD-1/PD-L1 interaction inhibitors described by Yangtze River, Shanghai Haiyan
Read More
Chengdu Huajian Future Technology patents IDO-1 inhibitors
Read More
New catalytic system allows selective cancer cell targeting
Read More
Roche describes new hepatitis B virus cccDNA formation inhibitors
Read More
Myovant Sciences presents phase II data on MVT-602 in premenopausal women
Read More
CB2 receptor PET radiotracer [11C]MDTC evaluated in first-in-human study
Read More
Equillium initiates phase Ib trial of itolizumab in uncontrolled moderate to severe asthma
Read More
Transgene gains U.K. MHRA approval for phase I study of TG-4050 for head and neck cancer
Read More
STAT3 could be a novel target for treating endometriosis
Read More
BioMarck reports phase II data on BIO-11006 in NSCLC
Read More
Radiolabeled GRP-R antagonist [177Lu]RM-2 evaluated in advanced prostate cancer patients
Read More
Regeneron studies REGN-5713-5714-5715 in healthy adults and subjects with birch pollen allergy
Read More
Novel collagen-targeted PET tracer: safety, distribution and detection of collagen deposition in IPF
Read More
Organotrifluoroborate as a theranostic synthon for PET imaging-guided BNCT
Read More
Preclinical and first-in-human studies of [18F]DASA-23, a radiopharmaceutical for glioblastoma
Read More
SO-C101 begins first-in-human study in advanced/metastatic solid tumors
Read More
